Sorrento Therapeutics, Inc. (SRNE)

USD 0.0

(0.0%)

Total Debt Summary of Sorrento Therapeutics, Inc.

  • Sorrento Therapeutics, Inc.'s latest annual total debt in 2022 was 134.5 Million USD , down -43.39% from previous year.
  • Sorrento Therapeutics, Inc.'s latest quarterly total debt in 2023 Q2 was 207.6 Million USD , up 22.44% from previous quarter.
  • Sorrento Therapeutics, Inc. reported annual total debt of 237.57 Million USD in 2021, up 40.25% from previous year.
  • Sorrento Therapeutics, Inc. reported annual total debt of 169.39 Million USD in 2020, down -41.75% from previous year.
  • Sorrento Therapeutics, Inc. reported quarterly total debt of 207.6 Million USD for 2023 Q2, up 22.44% from previous quarter.
  • Sorrento Therapeutics, Inc. reported quarterly total debt of 134.5 Million USD for 2022 Q4, down -20.04% from previous quarter.

Annual Total Debt Chart of Sorrento Therapeutics, Inc. (2022 - 2003)

Historical Annual Total Debt of Sorrento Therapeutics, Inc. (2022 - 2003)

Year Total Debt Total Debt Growth
2022 134.5 Million USD -43.39%
2021 237.57 Million USD 40.25%
2020 169.39 Million USD -41.75%
2019 290.78 Million USD 24.65%
2018 233.28 Million USD 4376.8%
2017 5.21 Million USD -88.99%
2016 47.31 Million USD 412.69%
2015 9.22 Million USD -24.02%
2014 12.14 Million USD 152.79%
2013 4.8 Million USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD -100.0%
2004 9537.00 USD 0.0%
2003 9537.00 USD 0.0%

Peer Total Debt Comparison of Sorrento Therapeutics, Inc.

Name Total Debt Total Debt Difference
America Great Health 1.87 Million USD -7091.681%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -48989.051%
Aridis Pharmaceuticals, Inc. 6.13 Million USD -2094.192%
Biora Therapeutics, Inc. 47.42 Million USD -183.608%
Bio-Path Holdings, Inc. 113 Thousand USD -118930.088%
Better Therapeutics, Inc. 14.88 Million USD -803.925%
Calithera Biosciences, Inc. 1.66 Million USD -7973.469%
Comera Life Sciences Holdings, Inc. 775.04 Thousand USD -17254.28%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 19.44 Million USD -591.715%
Eloxx Pharmaceuticals, Inc. 13.38 Million USD -904.961%
Evelo Biosciences, Inc. 51.13 Million USD -163.022%
Evolutionary Genomics, Inc. 3.74 Million USD -3492.764%
Finch Therapeutics Group, Inc. 30.12 Million USD -346.471%
Galera Therapeutics, Inc. 152.29 Million USD 11.684%
Innovation1 Biotech Inc. 228.99 Thousand USD -58635.628%
Kiromic BioPharma, Inc. 15.54 Million USD -765.395%
Molecular Templates, Inc. 12.23 Million USD -999.787%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD -5425.358%
NexImmune, Inc. 68.8 Thousand USD -195374.429%
Orgenesis Inc. 22.62 Million USD -494.598%
Panbela Therapeutics, Inc. 5.19 Million USD -2489.603%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Statera Biopharma, Inc. 16.26 Million USD -727.15%
TRACON Pharmaceuticals, Inc. 968 Thousand USD -13795.041%
Trevena, Inc. 35.23 Million USD -281.756%
Vaxxinity, Inc. 15.16 Million USD -786.762%
Vaccinex, Inc. 247 Thousand USD -54355.061%
Vicapsys Life Sciences, Inc. 353.86 Thousand USD -37909.653%
Viracta Therapeutics, Inc. 25.55 Million USD -426.311%
ZIVO Bioscience, Inc. 346.34 Thousand USD -38735.602%